Alimera Sciences Profit Margin

Alimera Sciences (ALIM) currently reports a profit margin of -14.74% as of June 2024. That compares with -46.61% in the prior-year period — up 68.4% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Alimera Sciences's profit margin history and peer comparisons.

Alimera Sciences's profit margin increased from -46.61% to -14.74% — a 68.4% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alimera Sciences's profit margin of -14.74% is lower than the Healthcare sector average of 15.29%. That is roughly 196.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Alimera Sciences's current -14.74% should be judged against Healthcare norms (sector average: 15.29%) and against ALIM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -14.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Alimera Sciences, and consider following ALIM for alerts when major investors trade the stock.